ActiGraph, which makes digital tools used in clinical trials, acquired the life sciences business of Biofourmis, once ...

In the world of drug development, the timing and design of clinical trials can be crucial in getting a new drug to market ...

PAH is a rare condition in children, but is often fatal if left untreated, and protocols for pediatric patients have not been ...

Over 300 Participants Have Completed Cumulative Six Months of Cytisinicline Treatment in the ORCA-OL Trial, Completing the Long-Term Exposure ...

Ryght AI, a leading provider of real-time generative AI solutions for the clinical research industry, and QPS Holdings, LLC (QPS), a global contract research organization (CRO), today announced a ...

The landscape of pandemic response has been transformed, with new standards being set for clinical excellence. A new report looks at emerging therapies, trial insights, and the innovations shaping the ...

Expected readouts in diabetes, cancer and depression headline a series of study results that could help the biotechnology ...

ActiGraph, the global leader in wearable digital health technology for clinical research and development, has announced the acquisition of Biofourmis Connect, a division of Biofourmis that delivers an ...

CytoMed Therapeutics has signed a business and research collaboration agreement with SunAct Cancer Institute for a clinical trial in India.

Participation in clinical trials typically includes comprehensive medical monitoring. Trial patients often receive additional ...

The Australian Government's Department of Health and Aged Care has announced the ‘2024 Clinical Trial Enabling Infrastructure ...